Pulmonary hypertension associated with disorders of the respiratory system;Hypertension pulmonaire des affections respiratoires chroniques

Presse Medicale

Volumn 34, Issue 19 II, 2005, Pages 1465-1474

  Chaouat, Ari ^a,b   Kraemer, J P ^a   Canuet, M ^a   Kadaoui, N ^a   Ducolone A ^a   Kessler, R ^a   Weitzenblum, E ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITALIS; DIURETIC AGENT; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE;

CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE EXACERBATION; EXERCISE; HEART FAILURE; HUMAN; HYPOXIA; LUNG VASOCONSTRICTION; MEAN ARTERIAL PRESSURE; OXYGEN THERAPY; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; PULMONARY ARTERY; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; REVIEW; SLEEP;

EID: 27744590984     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)84208-3     Document Type: Review

References (47)

1. Weitzenblum E. Chronic cor pulmonale. Heart 2003; 89: 225-30.
2. Fishman AP. Clinical classification of pulmonary hypertension. Clin Chest Med 2001; 22: 385-91.
3. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 5S-12S.
4. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-20.
5. Fishman AP. State of the art: chronic cor pulmonale. Am Rev Respir Dis 1976; 114: 775-94.
6. Flint FJ. Cor pulmonale; incidence and aetiology in an industrial city. Lancet 1954; 267: 51-8.
7. Behnke RH, Blount SG, Bristow JD, Carrieri V, Pierce JA, Sasahara A et al. Primary prevention of pulmonary heart disease. J Am Osteopath Assoc 1970; 69: 1139-46.
8. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducolone A et al. Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2005; 172: 189-94.
9. Williams BT, Nicholl JP. Prevalence of hypoxaemic chronic obstructive lung disease with reference to long-term oxygen therapy. Lancet 1985; 2: 369-72.
10. Calverley PM. The GOLD classification has advanced understanding of COPD. Am J Respir Crit Care Med 2004; 170: 211-2.
11. Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J et al. The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001; 120: 369-76.
12. Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996; 109: 380-6.
13. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. Am J Respir Crit Care Med 1994; 150: 833-52.
14. Von Euler US, Liljestrand G. Observation of the pulmonary arterial blood pressure in the cat. Acta Physio Scan 1946; 12: 301-20.
15. Archer S, Michelakis E. The mechanism(s) of hypoxic pulmonary vasoconstriction: potassium channels, redox 0(2) sensors, and controversies. News Physiol Sci 2002; 17: 131-7.
16. Wilkinson M, Langhorne CA, Heath D, Barer GR, Howard P. A pathophysiological study of 10 cases of hypoxic cor pulmonale. Q J Med 1988; 66: 65-85.
17. Wright JL, Petty T, Thurlbeck WM. Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial. Lung 1992; 170: 109-124.
18. Calverley PM, Howatson R, Flenley DC, Lamb D. Clinicopathological correlations in cor pulmonale. Thorax 1992; 47: 494-498.
19. Wagenvoort CA, Mulder PG. Thrombotic lesions in primary plexogenic arteriopathy. Similar pathogenesis or complication? Chest 1993; 103: 844-849.
20. Turato G, Zuin R, Saetta M. Pathogenesis and pathology of COPD. Respiration 2001; 68: 117-28.
21. Heath D. Remodeling of the pulmonary vasculature in hypoxic lung disease. In: Peacock AJ, ed. Pulmonary circulation. London: Chapman & Hall; 1996: 171-9.
22. Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet AS et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003; 108: 1839-44.
23. Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752-8.
24. Weitzenblum E, Ehrhart M, Rasaholinjanahary J, Hirth C. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration 1983; 44: 118-27.
25. Rich S, Dantzker DR, Ayres SM, Bergovfsky EH, Brundage BH, Detre KM et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216-23.
26. Palange P. Renal and hormonal abnormalities in chronic obstructive pulmonary disease (COPD). Thorax 1998; 53: 989-91.
27. Oswald-Mammosser M, Oswald T, Nyankiye E, Dickele MC, Grange D, Weitzenblum E. Non-invasive diagnosis of pulmonary hypertension in chronic obstructive pulmonary disease. Comparison of ECG, radiological measurements, echocardiography and myocardial scintigraphy. Eur J Respir Dis 1987; 71: 419-29.
28. Naeije R, Torbicki A. More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J 1995; 8: 1445-9.
29. Burghuber OC. Doppler assessment of pulmonary haemodynamics in chronic hypoxic lung disease. Thorax 1996; 51: 9-12.
30. Tramarin R, Torbicki A, Marchandise B, Laaban JP, Morpurgo M. Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Eur Heart J 1991; 12: 103-11.
31. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003; 167: 735-40.
32. Marchandise B, De Bruyne B, Delaunois L, Kremer R. Noninvasive prediction of pulmonary hypertension in chronic obstructive pulmonary disease by Doppler echocardiography. Chest 1987; 91: 361-5.
33. Swan HJ, Ganz W, Forrester J, Marcus H, Diamond G, Chonette D. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970; 283: 447-51.
34. Grandjean T. Une microtechnique du cathétérisme cardiaque droit praticable au lit du malade sans contrôle radioscopique. Cardiologia 1968; 51: 184-192.
35. Weitzenblum E, Loiseau A, Hirth C, Mirhom R, Rasaholinjanahary J. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Chest 1979; 75: 656-62.
36. Boushy SF, North LB. Hemodynamic changes in chronic obstructive pulmonary disease. Chest 1977; 72: 565-70.
37. Schrijen F, Uffholtz H, Polu JM, Poincelot F. Pulmonary and systemic hemodynamic evolution in chronic bronchitis. Am Rev Respir Dis 1978; 117: 25-31.
38. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Hirth C, Roegel E. Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130: 993-8.
39. Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducolone A et al. "Natural history" of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164: 219-24.
40. Jezek V, Fucik J, Michaljanic A, Jezkova L, Krasa H, Drechslerova J. Long-term development of pulmonary hypertension in interstitial lung fibrosis. XVth international congress of internal medicine, Prague. 1982; 236.
41. Chaouat A, Weitzenblum E, Kessler R, Oswald M, Sforza E, Liegeon MN et al. Five-year effects of nasal continuous positive airway pressure in obstructive sleep apnoea syndrome. Eur Respir J 1997; 10: 2578-82.
42. Vandenbergh E, Clement J, Van de Woestijne KP. Course and prognosis of patients with advanced chronic obstructive pulmonary disease. Evaluation by means of functional indices. Am J Med 1973; 55: 736-46.
43. Bishop JM, Cross KW. Physiological variables and mortality in patients with various categories of chronic respiratory disease. Bull Eur Physiopathol Respir 1984; 20: 495-500.
44. Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985; 102: 29-36.
45. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93: 391-8.
46. Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-6.
47. Chaouat A, Weitzenblum E. Prise en charge thérapeutiques des hypertensions artérielles pulmonaires. Presse Med 2002; 31: 320-8.